FICCI urges Centre to open vaccination for 18-45 years age group

FICCI has urged the government to ramp up COVID testing across the states

Coronavirus testing
A medic takes swab samples from passengers for COVID-19 tests, at Jammu Railway station
Press Trust of India New Delhi
2 min read Last Updated : Apr 03 2021 | 3:12 PM IST

Industry body FICCI has urged the government to ramp up COVID testing across the states and open up the vaccination for the age group 18-45 years, while assuring it of the complete support of the industry in fighting the pandemic.

"We are currently testing about 11 lakh samples a day, while we had reached the level of testing 15 lakh samples a day in January. Further, there is capacity of performing much more tests with 2,440 labs in the country operational for COVID testing, including more than 1,200 from the private sector," FICCI President Uday Shankar said in a letter to the Union Health & Family Welfare Minister Harsh Vardhan.

The states may be advised to utilise the facilities in the private sector to the maximum to achieve the desired testing capacity, he added.

Shankar also urged the government to open up vaccination for the age group of 18-45 years, as this age group has been acting as the superspreaders of infection in the country.

"Given that there is no shortage of vaccines and there is a huge scope of augmenting inoculation capacity through greater involvement of private sector, we urge you to open up vaccination for this age group to help subside the spread of infection as well as severity of cases in the country," he added.

Shankar alsoassured the government of complete support and cooperation of the industry in fighting this crisis.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusFICCICoronavirus VaccineCoronavirus Tests

First Published: Apr 03 2021 | 3:10 PM IST

Next Story